Canada markets open in 5 hours 23 minutes

Immunovant, Inc. (IMVT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
49.83+0.94 (+1.92%)
At close: 1:00PM EST
Currency in USD

Valuation Measures

Market Cap (intraday) 54.88B
Enterprise Value 34.44B
Trailing P/E N/A
Forward P/E 1-33.90
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-57.82

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 353.75
52 Week Low 38.34
50-Day Moving Average 345.93
200-Day Moving Average 333.07

Share Statistics

Avg Vol (3 month) 3513.27k
Avg Vol (10 day) 3309.38k
Shares Outstanding 597.89M
Float 33.5M
% Held by Insiders 160.45%
% Held by Institutions 140.71%
Shares Short (Nov. 12, 2020) 41.92M
Short Ratio (Nov. 12, 2020) 45.23
Short % of Float (Nov. 12, 2020) 43.80%
Short % of Shares Outstanding (Nov. 12, 2020) 41.97%
Shares Short (prior month Oct. 14, 2020) 42.53M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar. 30, 2020
Most Recent Quarter (mrq)Sep. 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-20.08%
Return on Equity (ttm)-38.23%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -76.75M
Net Income Avi to Common (ttm)-79.34M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)444.37M
Total Cash Per Share (mrq)4.54
Total Debt (mrq)3.78M
Total Debt/Equity (mrq)0.86
Current Ratio (mrq)35.15
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-65.48M
Levered Free Cash Flow (ttm)-37.75M